Mizuho Securities analyst Mario Corso offered commentary on Ironwood Pharmaceuticals (NASDAQ: IRWD) after Synergy (NASDAQ: SGYP) reported a positive Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Hot Comments Trader Talk

Synergy (SGYP) PT Lifted to $19 at Canaccord Genuity; 'This Thang Don't Stank'June 18, 2015 9:50 AM Ironwood Pharmaceuticals (IRWD) PT Trimmed at Wedbush on Positive Data from Competitor Synergy (SGYP)June 17, 2015 12:27 PM Synergy (SGYP) Seen as Attractive Takeout Target at Cantor Fitzgerald; PT Up to $14June 17, 2015 11:38 AM